<?xml-stylesheet type="text/xsl" href="varreports_v3.xsl"?><data_table name="RIAA" dataset_id="pht004157.v2" study_name="Atherosclerosis Risk in Communities (ARIC) Cohort" study_id="phs000280.v5" participant_set="1" date_created="2018/11/19"><description>Apolipoprotein A-I in Plasma by Radioimmunoassay, Exam 2. Participants with or without atherosclerosis and cardiovascular disease and involved in the "Atherosclerosis Risk in Communities (ARIC) Cohort" project.</description><variable id="phv00209386.v1.p1" var_name="RIAAFLAG" calculated_type="enum_integer" reported_type="encoded value"><description>Equal to 1 if form is present [Apolipoprotein A-I in Plasma by Radioimmunoassay, Cohort exam 2]</description><total><subject_profile><sex><male>6097</male><female>7345</female></sex></subject_profile><stats><stat n="13442" nulls="0" mean_count="13442" median_count="13442" min_count="13442" max_count="13442"/><enum code="1" count="13442">Presence</enum></stats></total></variable><variable id="phv00209386.v1.p1.c1" var_name="RIAAFLAG" calculated_type="enum_integer" reported_type="encoded value"><description>Equal to 1 if form is present [Apolipoprotein A-I in Plasma by Radioimmunoassay, Cohort exam 2]</description><total><subject_profile><sex><male>6091</male><female>7339</female></sex></subject_profile><stats><stat n="13430" nulls="0" mean_count="13430" median_count="13430" min_count="13430" max_count="13430"/><enum code="1" count="13430">Presence</enum></stats></total></variable><variable id="phv00209386.v1.p1.c2" var_name="RIAAFLAG" calculated_type="enum_integer" reported_type="encoded value"><description>Equal to 1 if form is present [Apolipoprotein A-I in Plasma by Radioimmunoassay, Cohort exam 2]</description><total><subject_profile><sex><male>6</male><female>6</female></sex></subject_profile><stats><stat n="12" nulls="0" mean_count="12" median_count="12" min_count="12" max_count="12"/><enum code="1" count="12">Presence</enum></stats></total></variable><variable id="phv00209387.v1.p1" var_name="RIAACY" calculated_type="integer" units="Year" reported_type="string"><description>Contact year [4] [Apolipoprotein A-I in Plasma by Radioimmunoassay, Cohort exam 2]</description><total><subject_profile><sex><male>6097</male><female>7345</female></sex></subject_profile><stats><stat n="13442" nulls="0" mean="4" sd="0" median="4" min="4" max="4"/><enum count="13442">4</enum></stats></total></variable><variable id="phv00209387.v1.p1.c1" var_name="RIAACY" calculated_type="integer" units="Year" reported_type="string"><description>Contact year [4] [Apolipoprotein A-I in Plasma by Radioimmunoassay, Cohort exam 2]</description><total><subject_profile><sex><male>6091</male><female>7339</female></sex></subject_profile><stats><stat n="13430" nulls="0" mean="4" sd="0" median="4" min="4" max="4"/><enum count="13430">4</enum></stats></total></variable><variable id="phv00209387.v1.p1.c2" var_name="RIAACY" calculated_type="integer" units="Year" reported_type="string"><description>Contact year [4] [Apolipoprotein A-I in Plasma by Radioimmunoassay, Cohort exam 2]</description><total><subject_profile><sex><male>6</male><female>6</female></sex></subject_profile><stats><stat n="12" nulls="0" mean="4" sd="0" median="4" min="4" max="4"/><enum count="12">4</enum></stats></total></variable><variable id="phv00209388.v1.p1" var_name="RIAA01A" calculated_type="integer" reported_type="string"><description>ApoA-I (value). Q1a [Apolipoprotein A-I in Plasma by Radioimmunoassay, Cohort exam 2]</description><total><subject_profile><sex><male>6018</male><female>7252</female></sex></subject_profile><stats><stat n="13270" nulls="22" mean="129.2" sd="31.2" median="126" min="31" max="409"/><example count="213">122</example><example count="203">127</example><example count="201">117</example><example count="193">120</example><example count="188">123</example><example count="183">129</example><example count="183">116</example><example count="181">126</example><example count="179">108</example><example count="179">134</example></stats></total></variable><variable id="phv00209388.v1.p1.c1" var_name="RIAA01A" calculated_type="integer" reported_type="string"><description>ApoA-I (value). Q1a [Apolipoprotein A-I in Plasma by Radioimmunoassay, Cohort exam 2]</description><total><subject_profile><sex><male>6012</male><female>7246</female></sex></subject_profile><stats><stat n="13258" nulls="22" mean="129.2" sd="31.21" median="126" min="31" max="409"/><example count="213">122</example><example count="202">127</example><example count="200">117</example><example count="193">120</example><example count="187">123</example><example count="183">129</example><example count="183">116</example><example count="181">126</example><example count="179">134</example><example count="178">108</example></stats></total></variable><variable id="phv00209388.v1.p1.c2" var_name="RIAA01A" calculated_type="integer" reported_type="string"><description>ApoA-I (value). Q1a [Apolipoprotein A-I in Plasma by Radioimmunoassay, Cohort exam 2]</description><total><subject_profile><sex><male>6</male><female>6</female></sex></subject_profile><stats><stat n="12" nulls="0" mean="124.9" sd="23.33" median="125" min="77" max="177"/><example count="1">127</example><example count="1">118</example><example count="1">135</example><example count="1">140</example><example count="1">131</example><example count="1">113</example><example count="1">77</example><example count="1">177</example><example count="1">117</example><example count="1">108</example></stats></total></variable><variable id="phv00209389.v1.p1" var_name="RIAA01B" calculated_type="integer" reported_type="string"><description>ApoA-I (run). Q1b [Apolipoprotein A-I in Plasma by Radioimmunoassay, Cohort exam 2]</description><total><subject_profile><sex><male>5927</male><female>7186</female></sex></subject_profile><stats><stat n="13113" nulls="329" mean="268.1" sd="47.52" median="277" min="32" max="2549"/><example count="434">0315</example><example count="329">0318</example><example count="326">0201</example><example count="294">0277</example><example count="250">0317</example><example count="241">0322</example><example count="238">0213</example><example count="220">0300</example><example count="207">0282</example><example count="203">0223</example></stats></total></variable><variable id="phv00209389.v1.p1.c1" var_name="RIAA01B" calculated_type="integer" reported_type="string"><description>ApoA-I (run). Q1b [Apolipoprotein A-I in Plasma by Radioimmunoassay, Cohort exam 2]</description><total><subject_profile><sex><male>5921</male><female>7180</female></sex></subject_profile><stats><stat n="13101" nulls="329" mean="268.1" sd="47.53" median="277" min="32" max="2549"/><example count="434">0315</example><example count="329">0318</example><example count="326">0201</example><example count="294">0277</example><example count="250">0317</example><example count="241">0322</example><example count="238">0213</example><example count="220">0300</example><example count="206">0282</example><example count="203">0223</example></stats></total></variable><variable id="phv00209389.v1.p1.c2" var_name="RIAA01B" calculated_type="integer" reported_type="string"><description>ApoA-I (run). Q1b [Apolipoprotein A-I in Plasma by Radioimmunoassay, Cohort exam 2]</description><total><subject_profile><sex><male>6</male><female>6</female></sex></subject_profile><stats><stat n="12" nulls="0" mean="271.8" sd="33.86" median="284" min="217" max="314"/><example count="2">0286</example><example count="1">0314</example><example count="1">0291</example><example count="1">0246</example><example count="1">0229</example><example count="1">0238</example><example count="1">0311</example><example count="1">0282</example><example count="1">0252</example><example count="1">0309</example></stats></total></variable><variable id="phv00209390.v1.p1" var_name="RIAA02A" calculated_type="integer" reported_type="string"><description>ApoB (value). Q2a [Apolipoprotein A-I in Plasma by Radioimmunoassay, Cohort exam 2]</description><total><subject_profile><sex><male>6022</male><female>7267</female></sex></subject_profile><stats><stat n="13289" nulls="21" mean="95.78" sd="28.55" median="93" min="0" max="336"/><example count="211">93</example><example count="207">89</example><example count="206">84</example><example count="206">87</example><example count="206">86</example><example count="205">75</example><example count="201">100</example><example count="200">102</example><example count="200">82</example><example count="200">80</example></stats></total></variable><variable id="phv00209390.v1.p1.c1" var_name="RIAA02A" calculated_type="integer" reported_type="string"><description>ApoB (value). Q2a [Apolipoprotein A-I in Plasma by Radioimmunoassay, Cohort exam 2]</description><total><subject_profile><sex><male>6016</male><female>7261</female></sex></subject_profile><stats><stat n="13277" nulls="21" mean="95.79" sd="28.55" median="93" min="0" max="336"/><example count="210">93</example><example count="207">89</example><example count="206">84</example><example count="206">87</example><example count="206">86</example><example count="205">75</example><example count="201">100</example><example count="200">102</example><example count="200">82</example><example count="200">80</example></stats></total></variable><variable id="phv00209390.v1.p1.c2" var_name="RIAA02A" calculated_type="integer" reported_type="string"><description>ApoB (value). Q2a [Apolipoprotein A-I in Plasma by Radioimmunoassay, Cohort exam 2]</description><total><subject_profile><sex><male>6</male><female>6</female></sex></subject_profile><stats><stat n="12" nulls="0" mean="87.33" sd="25.49" median="80.5" min="54" max="137"/><example count="1">71</example><example count="1">93</example><example count="1">67</example><example count="1">124</example><example count="1">64</example><example count="1">83</example><example count="1">78</example><example count="1">137</example><example count="1">99</example><example count="1">108</example></stats></total></variable><variable id="phv00209391.v1.p1" var_name="RIAA02B" calculated_type="integer" reported_type="string"><description>ApoB (run). Q2b [Apolipoprotein A-I in Plasma by Radioimmunoassay, Cohort exam 2]</description><total><subject_profile><sex><male>5906</male><female>7106</female></sex></subject_profile><stats><stat n="13012" nulls="430" mean="271.1" sd="49.08" median="280" min="0" max="2134"/><example count="242">0322</example><example count="200">0280</example><example count="185">0290</example><example count="178">0321</example><example count="172">0291</example><example count="172">0334</example><example count="170">0244</example><example count="168">0285</example><example count="159">0309</example><example count="154">0324</example></stats></total></variable><variable id="phv00209391.v1.p1.c1" var_name="RIAA02B" calculated_type="integer" reported_type="string"><description>ApoB (run). Q2b [Apolipoprotein A-I in Plasma by Radioimmunoassay, Cohort exam 2]</description><total><subject_profile><sex><male>5900</male><female>7101</female></sex></subject_profile><stats><stat n="13001" nulls="429" mean="271.1" sd="49.08" median="280" min="0" max="2134"/><example count="242">0322</example><example count="200">0280</example><example count="184">0290</example><example count="176">0321</example><example count="172">0291</example><example count="172">0334</example><example count="170">0244</example><example count="167">0285</example><example count="159">0309</example><example count="154">0324</example></stats></total></variable><variable id="phv00209391.v1.p1.c2" var_name="RIAA02B" calculated_type="integer" reported_type="string"><description>ApoB (run). Q2b [Apolipoprotein A-I in Plasma by Radioimmunoassay, Cohort exam 2]</description><total><subject_profile><sex><male>6</male><female>5</female></sex></subject_profile><stats><stat n="11" nulls="1" mean="273.7" sd="39.5" median="285" min="216" max="321"/><enum count="2">0321</enum><enum count="1">0247</enum><enum count="1">0285</enum><enum count="1">0290</enum><enum count="1">0216</enum><enum count="1">0297</enum><enum count="1">0224</enum><enum count="1">0250</enum><enum count="1">0241</enum><enum count="1">0319</enum></stats></total></variable><variable id="phv00209392.v2.p1" var_name="SUBJECT_ID" calculated_type="string" reported_type="string"><description>ARIC subject ID  [Apolipoprotein A-I in Plasma by Radioimmunoassay, Cohort exam 2]</description><total><subject_profile><sex><male>6097</male><female>7345</female></sex></subject_profile><stats><stat n="13442" nulls="0"/></stats></total></variable><variable id="phv00209392.v2.p1.c1" var_name="SUBJECT_ID" calculated_type="string" reported_type="string"><description>ARIC subject ID  [Apolipoprotein A-I in Plasma by Radioimmunoassay, Cohort exam 2]</description><total><subject_profile><sex><male>6091</male><female>7339</female></sex></subject_profile><stats><stat n="13430" nulls="0"/></stats></total></variable><variable id="phv00209392.v2.p1.c2" var_name="SUBJECT_ID" calculated_type="string" reported_type="string"><description>ARIC subject ID  [Apolipoprotein A-I in Plasma by Radioimmunoassay, Cohort exam 2]</description><total><subject_profile><sex><male>6</male><female>6</female></sex></subject_profile><stats><stat n="12" nulls="0"/></stats></total></variable></data_table>
